Expanding Market Presence Acurable is actively expanding its footprint into the US market with the launch of the AcuPebble device for Obstructive Sleep Apnoea, providing a strategic opportunity to target healthcare providers and sleep clinics nationwide seeking innovative, at-home diagnostic solutions.

Strong Venture Support With significant Series A funding from NHS and venture capital firms, Acurable demonstrates robust financial backing, enabling aggressive sales efforts and partnership developments in both European and North American markets, especially within healthcare institutions looking for advanced respiratory diagnostic tools.

Strategic Partnerships Collaborations with companies like Nyxoah indicate a strong pipeline for distributing home sleep testing devices, presenting sales opportunities to establish partnerships with sleep disorder specialists and medical device distributors across Europe and beyond.

Regulatory Approvals Acurable’s achievement of CE marking and FDA clearance for its products positions it as a trusted provider with accessible regulatory approval, facilitating easier penetration into hospital systems, clinics, and home healthcare providers seeking compliant and innovative respiratory diagnostics.

Product Innovation & Research Ongoing research into devices for managing chronic respiratory conditions like COPD and asthma opens avenues for cross-selling complementary health monitoring solutions to specialists and healthcare networks focused on respiratory care management.